Price is syncing
Reported smart-money activity is still available below.
1 month
-0.3%
price return
Year to date
-0.2%
price return
Big funds
8
hold this stock
News tone
Bullish
19 articles, 7 days
Filed positions and reported activity tied to this stock.
8 funds hold a position.
Real smart money
Recent coverage and its overall tone.
News
Coverage is bullish
15 bullish · 3 neutral · 1 bearish
Tone of tracked coverage
Africa’s most developed pharmaceutical market reviews 12 Ozempic generics as drugmakers target Novo Nordisk’s dominance
Leans bearishJul 21Novo Nordisk Ramps Up DKK 15 Billion Share Buyback Programme
Leans bullishJul 21Aspen Pharmacare wins Canada approval for generic Ozempic after Novo patent expiry
NeutralJul 20Citi lifts Novo Nordisk target on strong GLP-1 pill launch
Leans bullishJul 20Novo Nordisk launches cheaper Ozempic in South Africa
BullishJul 20Ozempic maker launches cheaper copy in Africa’s largest pharma market after court blocks unregistered Ozempic copies
Leans bullishJul 18Novo Nordisk to launch lower-cost Ozempic copy in South Africa
NeutralJul 18Novo Nordisk: EU Approval of Wegovy Pill Expands Opportunity, but Cash Pay Raises Systematic Risk
NeutralJul 17JPMorgan Chase
Q1 2026 13F
$99.1M
position
AlphaYou
